Sudden Cardiac Arrest in Hypertrophic Cardiomyopathy in the Absence of Conventional Criteria for High Risk Status

American Journal of Cardiology

Volumn 101, Issue 4, 2008, Pages 544-547

  Maron, Barry J ^a   Maron, Martin S ^b   Lesser, John R ^a   Hauser, Robert G ^a   Haas, Tammy S ^a   Harrigan, Caitlin J ^c,d   Appelbaum, Evan ^c,d   Main, Michael L ^e   Roberts, William C ^f  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL;

ADOLESCENT; ADULT; ARTICLE; AUTOPSY; CARDIOGENIC SHOCK; CASE REPORT; CONTRAST ENHANCEMENT; DEFIBRILLATOR; HEART ARREST; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART PAPILLARY MUSCLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SCAR FORMATION; SINUS RHYTHM; SUDDEN DEATH;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; ATENOLOL; CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; FATAL OUTCOME; HEART ARREST; HEART SEPTUM; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIUM; PAPILLARY MUSCLES; VENTRICULAR FIBRILLATION;

EID: 38849097178     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.101     Document Type: Article

References (19)

1. Maron B.J., Spirito P., Shen W.-K., Haas T.S., Formisano F., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Lawrenz T., et al. Outcomes of patients with implantable cardioverter-defibrillators for prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412
2. Maron B.J., Shen W.-K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 365-373
3. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer W.H., Spirito P., ten Cate F.J., and Wigle E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 42 (2003) 1687-1713
4. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monsererat L., Varnava A., Mahon N.G., and McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
5. Rickers C., Wilke N.M., Jerosch-Herold M., Casey S.A., Panse P., Panse N., Weil J., Zenovich A.G., and Maron B.J. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112 (2005) 855-861
6. Jayatilleke I., Doolan A., Ingles J., McGuire M., Booth V., Richmond D.R., and Semsarian C. Long-term follow-up of implantable cardioverter-defibrillator therapy for hypertrophic cardiomyopathy. Am J Cardiol 93 (2004) 1192-1194
7. Kim R.J., and Judd R.M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?. J Am Coll Cardiol 41 (2003) 1568-1572
8. Moon J.C., Reed E., Sheppard M.N., Elkington A.G., Ho S.Y., Burke M., Petrou M., and Pennell D.J. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
9. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
10. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
11. Maron B.J., Wolfson J.K., Epstein S.E., and Roberts W.C. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8 (1986) 545-557
12. Basso C., Thiene G., Corrado D., Buja G., Melacini P., and Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31 (2000) 988-998
13. Maron B.J., and Roberts W.C. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59 (1979) 689-706
14. Yetman A.T., McCrindle B.W., MacDonald C., Freedom R.M., and Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy-a risk factor for sudden death. N Engl J Med 339 (1998) 1201-1209
15. Harrigan C.J., Appelbaum E., Gibson C.M., Udelson J.E., Manning W.J., Maron B.J., and Maron M.S. Evidence for papillary muscle involvement in hypertrophic cardiomyopathy by cardiac magnetic resonance. (abstr). J Cardiovasc Magn Reson 9 (2007) 428
16. Roberts W.C., and Cohen L.S. Left ventricular papillary muscles. Description of the normal and a survey of conditions causing them to be abnormal. Circulation 46 (1972) 138-154
17. Marcus F.I., Gomez L., Glancy D.L., Ewy G.A., and Roberts W.C. Papillary muscle fibrosis in primary myocardial disease. Am Heart J 77 (1969) 681-685
18. Berezowski K., Mautner G.C., and Roberts W.C. Scarring of the left ventricular papillary muscles in sickle-cell disease. Am Heart J 70 (1992) 1368-1370
19. Papavassiliu T., Schnabel P., Schröder M., and Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 26 (2005) 2395